
Renalytix AI plc RNLX
Quartalsbericht 2024-Q3
hinzugefügt 19.11.2024
Renalytix AI plc EV/EBITDA 2011-2026 | RNLX
EV/EBITDA Jährlich Renalytix AI plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -32.1 | -44.1 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.1 | -44.1 | -38.1 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.95 | -1.97 % | $ 957 M | ||
|
Agilent Technologies
A
|
27.4 | $ 115.26 | -0.19 % | $ 35 B | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 166.68 | -4.15 % | $ 8.26 B | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 25.08 | 0.95 % | $ 697 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 191.97 | 0.44 % | $ 137 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
DexCom
DXCM
|
39.5 | $ 62.95 | 1.17 % | $ 24.6 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.54 | -1.66 % | $ 500 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-28.8 | $ 90.17 | -3.9 % | $ 11.3 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 16.03 | -1.06 % | $ 173 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 110.02 | -3.65 % | $ 9.07 B | ||
|
Illumina
ILMN
|
70.5 | $ 127.46 | 0.06 % | $ 20.3 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 170.2 | -1.77 % | $ 29.3 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 274.39 | 0.24 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 76.15 | 0.07 % | $ 5.14 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 496.01 | -0.47 % | $ 14.3 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 265.73 | 0.46 % | $ 26.1 B | ||
|
ENDRA Life Sciences
NDRA
|
0.831 | $ 4.56 | -2.72 % | $ 3.59 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 7.94 | -0.73 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.46 | 0.53 % | $ 2.05 B | ||
|
National Research Corporation
NRC
|
21 | $ 17.42 | 1.52 % | $ 390 M | ||
|
Biodesix
BDSX
|
-4.25 | $ 15.96 | 5.91 % | $ 2.07 B | ||
|
Natera
NTRA
|
-19.5 | $ 204.3 | -1.77 % | $ 20.1 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.42 | 5.6 % | $ 426 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.17 | 0.2 % | $ 20 B | ||
|
Precipio
PRPO
|
-1.8 | $ 26.25 | 3.35 % | $ 42.1 M | ||
|
Personalis
PSNL
|
-7.07 | $ 6.59 | 0.15 % | $ 390 M | ||
|
RadNet
RDNT
|
17.6 | $ 55.09 | 0.55 % | $ 4.14 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.81 | -1.3 % | $ 284 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Sotera Health Company
SHC
|
24.8 | $ 14.86 | -0.67 % | $ 4.22 B | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.3 | 32.43 % | $ 2.66 B | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.79 | 17.76 % | $ 118 M | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 485.83 | -1.15 % | $ 183 B |